1. Home
  2. ASYS vs CTMX Comparison

ASYS vs CTMX Comparison

Compare ASYS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$12.76

Market Cap

175.2M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.13

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
CTMX
Founded
1981
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.2M
596.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ASYS
CTMX
Price
$12.76
$4.13
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.50
AVG Volume (30 Days)
188.0K
2.9M
Earning Date
02-04-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$79,364,000.00
$113,631,000.00
Revenue This Year
$12.14
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$16.70
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$0.40
52 Week High
$12.65
$4.62

Technical Indicators

Market Signals
Indicator
ASYS
CTMX
Relative Strength Index (RSI) 84.02 54.99
Support Level $11.89 $3.86
Resistance Level $12.65 $4.37
Average True Range (ATR) 0.81 0.25
MACD 0.34 -0.02
Stochastic Oscillator 90.23 65.73

Price Performance

Historical Comparison
ASYS
CTMX

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: